What is the HCAT stock price prediction for next 2 weeks?

According to our price prediction algorithm,Health Catalyst, Inc. (HCAT) price will be around $2.27 in the next 2 weeks. This means it will increase by 11.318627450980397 from the last closing price. This prediction may vary from other time period filters for HCAT stock.

What can be the highest Possible price of HCAT stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, HCAT can achieve the highest price of $2.42 which is 18.844752849094 higher than last closing price. This prediction may vary from other time period filters for HCAT stock.

What can be the lowest Possible price of HCAT stock in next 2 weeks?

As per the forecast and algorithmic analysis, HCAT stock price can be as low as $2.11 which is 3.560038961213483 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for HCAT stock.

Will HCAT stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that HCAT stock will gain11.318627450980397 in the next 2 weeks. This prediction may vary from other time period filters for HCAT stock.

What is HCAT stock last closing price?

Last closing price of HCAT stock was $2.01.

What is HCAT stock price prediction?

HCAT stock price prediction means predicting the future closing prices of HCAT stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of HCAT stock in a certain time period.

How we predict HCAT stock future prices?

If you are searching for HCAT stock forecast, analysis or price prediction, then you might be wondering what Health Catalyst, Inc. (HCAT) will do in the future. Our HCAT price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This HCAT price prediction will likely answer most of your questions.

How frequent we update HCAT stock predictions?

We are updating the forecasts for the HCAT stock on daily basis.

Is using ML forecasting for HCAT stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for HCAT stock same for all the time periods?

No, the prediction for HCAT stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Health Catalyst, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.01-10.27%Since 2 Weeks

Predicted Price$2.2711.32%For 2 Weeks

Upper Predicted Price$2.4218.84%For 2 Weeks

Lower Predicted Price$2.113.56%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of HCAT will rise by +11.32% over the next 2 Weeks and hit $2.27 by Wednesday, August 5, 2026. In that time frame, HCAT's share price is expected to range between $2.11 and $2.42.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 5, 2026	2.11	2.27	2.42
Aug 4, 2026	2.16	2.32	2.48
Aug 3, 2026	2.12	2.28	2.43
Jul 31, 2026	2.19	2.34	2.49
Jul 30, 2026	2.09	2.25	2.42
Jul 29, 2026	2.00	2.16	2.31
Jul 28, 2026	2.04	2.21	2.36
Jul 27, 2026	2.00	2.17	2.32
Jul 24, 2026	2.08	2.23	2.38
Jul 23, 2026	1.98	2.14	2.30

HCAT shares fell -1.47% in Thursday, July 23, 2026's trading session, dropping from a previous close of $2.04 to move at $2.01. The stock demonstrated notable intraday movement (see HCAT's key stats for a full breakdown), fluctuating between $2.01 and $2.05, a +1.99% trading range. While recent weeks have seen some volatility, HCAT has managed to secure a -12.23% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 388.52K shares changing hands, 84.16K fewer than the previous session. This amounted to $780.92K in total market activity.

Will HCAT Continue Its Upward Trend?

According to analyst ratings and projections for HCAT, Health Catalyst, Inc. shares are anticipated to increase by +17.09%, potentially reaching $2.42 per share by August 5, 2026. Short-term technical indicators currently suggest a neutral sentiment for HCAT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the HCAT stock forecast, now is a good time to buy HCAT stock because its current trading price is -11.49% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on HCAT covering social and institutional perspectives.

HCAT Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into HCAT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.49% to 52.99%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.92%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.86%, maintains a neutral outlook for the long term. Insights into HCAT's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Health Catalyst Short-Term Forecasts

HCAT Forecast For Next 5 Days

Our algorithm anticipates Health Catalyst (HCAT) stock could hit $2.20 by Jul 30, 2026. This represents a +9.38% fall from today's price, following a -10.16% change over the past five days.

HCAT Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Health Catalyst, Inc. (HCAT) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $2.29, which would mean a +13.93% increase from the current price of $2.01. Projections for this period range from a high of $2.82 to a low of $1.85.

HCAT Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Health Catalyst's price over the next three months point to a rise. HCAT stock is expected to peak at $5.01 on Jul 23, 2026 before potentially dipping to $3.24 on Oct 23, 2026. On average, HCAT is likely to trade around $4.15 in the coming 90 days.

Health Catalyst Stock Forecast 2025

Based on our predictive models, Health Catalyst (HCAT) is expected to trade between $2.29 and $5.01 throughout 2026. This would result in an average price of $3.93, potentially offering investors a +95.52% return from current levels.

Health Catalyst, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in July 2026. The price is predicted to move between $4.61 and $5.01, settling at an average of $4.81. This could translate to a +139.30% gain.

August 2026

Based on current market signals, Health Catalyst, Inc. is projected to trend august 2026. We forecast a trading range from $3.78 to $4.80, with a likely average price of $4.22. Investors could expect a potential return of +109.95%.

September 2026

Our predictive algorithms indicate Health Catalyst, Inc. stock may see a shift in September 2026. The expected range spans $3.78–$4.27, with an average target of $4.05. This represents a positive outlook and a possible gain of +101.49%.

October 2026

Analyzing established trends, Health Catalyst, Inc. looks set to move in October 2026. Projections place the stock between $3.06 and $4.25, averaging around $3.82. This suggests a +90.05% gain from current levels.

November 2026

Market indicators suggest Health Catalyst, Inc. could experience notable changes during November 2026. Prices could fluctuate within $2.99 to $3.93, with a midpoint forecast of $3.66. The stock might deliver a +82.09% gain.

December 2026

Forecasting for December 2026, models estimate that Health Catalyst, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.29 and $3.95, averaging $3.65. This signals a positive trajectory with potential returns around +81.59%.

January 2027

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in January 2027. The price is predicted to move between $1.27 and $3.37, settling at an average of $3.06. This could translate to a +52.24% gain.

February 2027

Based on current market signals, Health Catalyst, Inc. is projected to trend february 2027. We forecast a trading range from $0.56 to $2.47, with a likely average price of $2.53. Investors could expect a potential return of +25.87%.

March 2027

Our predictive algorithms indicate Health Catalyst, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$1.98, with an average target of $2.20. This represents a positive outlook and a possible gain of +9.45%.

April 2027

Analyzing established trends, Health Catalyst, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $1.37, averaging around $1.97. This suggests a -1.99% loss from current levels.

May 2027

Market indicators suggest Health Catalyst, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $1.19, with a midpoint forecast of $2.21. The stock might deliver a +9.95% gain.

June 2027

Forecasting for June 2027, models estimate that Health Catalyst, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.80, averaging $2.15. This signals a positive trajectory with potential returns around +6.97%.

July 2027

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.34, settling at an average of $2.25. This could translate to a +11.94% gain.

HCAT's history of dividends and stock splits also plays a role in long-term investor confidence.